Erytech

Conditions are ripe for reverse mergers
EP Vantage
Fri, 02/24/23 - 08:48 am
M&A
reverse merger
Redx
Jounce Therapeutics
Pherecydes
Erytech
Flame Biosciences
Leap Therapeutics
Elicio Therapeutics
Angion
Biotech consolidation continues as Nasdaq-listed Erytech merges with phage therapy developer
Endpoints
Thu, 02/16/23 - 10:29 am
Erytech
NASDAQ
Pferecydes
M&A
The quest for efficacy in pancreatic cancer
EP Vantage
Thu, 11/11/21 - 10:53 am
pancreatic cancer
Novartis
FibroGen
Tyme Technologies
Erytech
Rafeal Pharmaceuticals
A transatlantic biotech flags a painful PhIII cancer flop, waving a white flag
Endpoints
Mon, 10/25/21 - 10:49 am
Erytech
clinical trials
eryapase
pancreatic cancer
Erytech raises €25M to broaden cancer pipeline ahead of possible Nasdaq IPO
Fierce Biotech
Wed, 12/9/15 - 09:37 pm
Erytech
Graspa
tumor starvation
IPOs